| 1 |
Gao C, Zhao XX, Li WJ, et al. Clinical features, early treatment responses, and outcomes of pediatric acute lymphoblastic leukemia in China with or without specific fusion transcripts: a single institutional study of 1 004 patients[J].Am J Hematol, 2012, 87(11):1022-1027.
|
| 2 |
Golub TR, Slonim DK, Tamayo C, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring[J]. Science, 1999, 286(4):532-537.
|
| 3 |
Yeoh EJ, Ross ME, Shurtleff SA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling[J]. Cancer Cell, 2002, 1(2):133-143.
|
| 4 |
Ross ME, Zhou XD, Song GC, et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling[J]. Blood, 2003, 102(8):2951-2959.
|
| 5 |
Li Z, Zhang W, Wu M, et al. Gene expression-based classification and regulatory networks of pediatric acute lymphoblastic leukemia[J]. Blood, 2009, 114(20):4486-4493.
|
| 6 |
Chen QR, Vansant G, Oades K, et al. Diagnosis of the small round blue cell tumors using multiplex polymerase chain reaction[J]. J Mol Diagn, 2007, 9(1):80-88.
|
| 7 |
Rai AJ, Kamath RM, Gerald W, et al. Analytical validation of the GeXP analyzer and design of a workflow for cancer-biomarker discovery using multiplexed gene-expression profiling[J]. Anal Bioanal Chem, 2009, 393(5):1505-1511.
|
| 8 |
Drew JE, Mayer CD, Farquharson AJ, et al.Custom design of a GeXP multiplexed assay used to assess expression profiles of inflammatory gene targets in normal colon, polyp, and tumor tissue[J].J Mol Diagn, 2011, 13(2):233-242.
|
| 9 |
孟晋，蒋怡然，袁文祺，等．肽处理相关基因在良恶性嗜铬细胞瘤鉴别中的意义[J]．中华内分泌代谢杂志，2009，25(5)：496-497.
|
| 10 |
Zhang PJ, Run WW, Wang PL, et al.Peripheral blood mRNA expression patterns to differentiate hepatocellular carcinoma from other hepatic diseases[J].Front Biosci, 2012, 1(4):620-630.
|
| 11 |
Den Boer ML, van Slegtenhorst M, De Menezes RX, et al. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study[J]. Lancet Oncol, 2009, 10(2):125-134.
|
| 12 |
Mullighan CG, Su X, Zhang J, et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia[J]. N Engl J Med, 2009, 360(5):470-480.
|
| 13 |
Kuiper RP, Waanders E, van der Velden VH, et al. IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL[J]. Leukemia, 2010, 24(7):1258-1264.
|
| 14 |
Ley TJ, Mardis ER, Ding L, et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome[J]. Nature, 2008, 456(1):66-72.
|
| 15 |
Mardis ER, Ding L, Dooling DJ, et al. Recurring mutations found by sequencing an acute myeloid leukemia genome[J]. N Engl J Med, 2009, 361(11):1058-1066.
|
| 16 |
Ley TJ, Ding L, Walter MJ, et al. DNMT3A mutations in acute myeloid leukemia[J]. N Engl J Med, 2010, 363(25):2424-2433.
|
| 17 |
Tiacci E, Trifonov V, Schiavoni G, et al. BRAF mutations in hairy-cell leukemia[J]. N Engl J Med, 2011, 364(24):2305-2315.
|
| 18 |
The Cancer Genome Atlas Research Network. Integrated genomic characterization of endometrial carcinoma[J]. Nature, 2013, 497(1):67-73.
|
| 19 |
The Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia[J]. N Engl J Med, 2013, 368(22):2059-2074.
|